0001127602-12-020208.txt : 20120618 0001127602-12-020208.hdr.sgml : 20120618 20120618135343 ACCESSION NUMBER: 0001127602-12-020208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120615 FILED AS OF DATE: 20120618 DATE AS OF CHANGE: 20120618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALEXANDER SUSAN H CENTRAL INDEX KEY: 0001263839 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 12911994 MAIL ADDRESS: STREET 1: C/O BIOGEN IDEC INC. STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-06-15 0000875045 BIOGEN IDEC INC. BIIB 0001263839 ALEXANDER SUSAN H BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON MA 02493 1 EVP, General Counsel Common Stock 2012-06-15 4 M 0 20000 45.72 A 30185 D Common Stock 2012-06-15 4 M 0 29800 49.31 A 59985 D Common Stock 2012-06-15 4 S 0 49800 140.00 D 10185 D Stock Option (Right to Buy) 45.72 2012-06-15 4 M 0 20000 0 D 2016-02-15 Common Stock 20000 0 D Stock Option (Right to Buy) 49.31 2012-06-15 4 M 0 29800 0 D 2017-02-12 Common Stock 29800 0 D Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d). The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/15/06. The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07. Aras Lapinskas, Attorney in Fact for Susan H. Alexander 2012-06-18